Rocket Lab's Stock Dives 4.89% on $1.73B Volume Surge, Ranking 87th in Market Activity Amid Neutron Delays and Financial Woes

Market Snapshot

Rocket Lab (RKLB) experienced a significant drop in its stock price, falling 4.89% on 2026-02-27, despite a surge in trading volume. The company’s shares traded at a daily volume of $1.73 billion, reflecting a 32.1% increase from the previous day and ranking 87th in market activity. This divergence between volume and price highlights investor uncertainty, as strong engagement in the stock coincided with downward pressure on its valuation.

Key Drivers

Rocket Lab’s Q4 2025 earnings report delivered mixed signals, contributing to the stock’s volatility. The company reported record annual revenue of $602 million, a 38% year-on-year increase, driven by 21 successful Electron and HASTE missions in 2025. Additionally, the backlog surged to $1.85 billion, up 73% year-on-year, bolstered by an $816 million contract with the Space Development Agency (SDA) for satellite production. These figures underscore robust operational execution and long-term demand for the company’s launch and space systems services. However, the stock’s decline suggests investors prioritized near-term risks over these positives.

A critical factor behind the stock’s drop was the delay in the Neutron rocket’s first launch, now targeted for Q4 2026. During the earnings call, CEO Peter Beck attributed the delay to a Stage 1 tank hydrostatic test failure caused by a third-party manufacturing defect. While the company has implemented automated production to prevent recurrence, the setback raised concerns about Neutron’s timeline and potential cost overruns. Neutron, a key growth driver, is intended to expand Rocket Lab’s capacity for medium-lift launches, but its delayed debut may hinder revenue diversification and market confidence in the company’s technological edge.

Financial guidance for Q1 2026 further weighed on sentiment. Rocket LabRKLB-- projected revenue between $185 million and $200 million, with GAAP gross margins expected to decline to 34–36% due to a shift toward lower-margin space systems. The company also anticipates an adjusted EBITDA loss of $21–27 million, driven by elevated Neutron development costs and production scaling. CFO Adam Spice acknowledged that Q1 would mark “peak Neutron R&D spending,” signaling a temporary cash flow strain. These figures contrast with the company’s record Q4 gross margins of 38%, highlighting near-term financial pressures despite strong revenue growth.

Strategic acquisitions and vertical integration efforts, while positive for long-term positioning, added complexity. Rocket Lab completed the acquisition of Optical Support, Inc. and Precision Components Limited in Q1 2026, enhancing in-house manufacturing capabilities for optical systems and precision components. While these moves strengthen the company’s supply chain resilience, they also require upfront capital and operational integration costs. Additionally, the pending acquisition of Mynaric, a German laser communication company, remains subject to regulatory approval, introducing further uncertainty.

The stock’s decline reflects investor skepticism about Rocket Lab’s ability to balance near-term execution risks with long-term growth. While the SDA contract and expanded backlog demonstrate strong demand, the Neutron delay and elevated R&D costs have raised concerns about cash burn and margin compression. Analysts noted that the company’s free cash flow remains negative, with $114.2 million used in Q4 2025, and adjusted EBITDA losses expected to persist in Q1. However, Rocket Lab’s leadership in small satellite launches and its vertically integrated approach to space systems remain competitive advantages, potentially mitigating long-term risks. The market will likely continue to monitor Neutron’s progress and the pace of backlog conversion into revenue as key indicators of the company’s trajectory.